We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$237M
AUM Growth
-$13.8M
Cap. Flow
-$6.52M
Cap. Flow %
-2.75%
Top 10 Hldgs %
59.31%
Holding
121
New
11
Increased
20
Reduced
8
Closed
10
Avg Time Held
2.4 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.3 years

Sector Composition

Rank Sector Weight
1 Healthcare 32.14%
2 Industrials 13.86%
3 Technology 10.97%
4 Consumer Discretionary 9.86%
5 Energy 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LXRX icon
76
Lexicon Pharmaceuticals
LXRX
$676M
$189K 0.08%
30,000
– –
2019 Q1
1 quarter
MSFT icon
77
Microsoft
MSFT
$3.93T
$188K 0.08%
1,400
– –
2013 Q2
24 quarters
FSBW icon
78
FS Bancorp
FSBW
$353M
$186K 0.08%
7,154
– –
2018 Q4
2 quarters
CSFL
79
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$160K 0.07%
6,942
– –
2018 Q1
5 quarters
CBAY icon
80
DELISTED
Cymabay Therapeutics
CBAY
$150K 0.06%
+21,000
New +$238K
2019 Q2
0 quarters
ORIT
81
DELISTED
Oritani Financial Corp. New
ORIT
$137K 0.06%
7,800
– –
2013 Q2
24 quarters
CFFN icon
82
Capitol Federal Financial
CFFN
$1.01B
$135K 0.06%
9,800
-661,250
-99% -$8.97M
2013 Q2
24 quarters
VRCA icon
83
Verrica Pharmaceuticals
VRCA
$61.8M
$129K 0.05%
+1,111
New +$104K
2019 Q2
0 quarters
CUZ icon
84
Cousins Properties
CUZ
$4.55B
$121K 0.05%
3,357
– –
2015 Q1
17 quarters
LEGH icon
85
Legacy Housing
LEGH
$651M
$112K 0.05%
9,000
– –
2018 Q4
2 quarters
OFIX icon
86
Orthofix Medical
OFIX
$382M
$106K 0.04%
2,000
– –
2019 Q1
1 quarter
FNB icon
87
FNB Corp
FNB
$6.13B
$105K 0.04%
8,905
– –
2014 Q3
19 quarters
MDT icon
88
Medtronic
MDT
$121B
$102K 0.04%
1,050
– –
2014 Q3
19 quarters
LITS icon
89
Lite Strategy Inc
LITS
$35M
$96K 0.04%
1,930
– –
2017 Q3
7 quarters
NVLN
90
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$85K 0.04%
109,135
– –
2016 Q4
10 quarters
GMED icon
91
Globus Medical
GMED
$10.3B
$80K 0.03%
1,900
– –
2019 Q1
1 quarter
F icon
92
Ford
F
$49.6B
$51K 0.02%
5,000
– –
2017 Q3
7 quarters
GE icon
93
GE Aerospace
GE
$326B
$50K 0.02%
939
– –
2013 Q2
24 quarters
ALC icon
94
Alcon
ALC
$32B
$37K 0.02%
+600
New +$35.2K
2019 Q2
0 quarters
LLY icon
95
Eli Lilly
LLY
$1.12T
$33K 0.01%
300
– –
2013 Q3
23 quarters
CC icon
96
Chemours
CC
$1.92B
$32K 0.01%
1,360
– –
2015 Q3
15 quarters
PBCT
97
DELISTED
People's United Financial Inc
PBCT
$25K 0.01%
1,500
– –
2019 Q1
1 quarter
BNS icon
98
Scotiabank
BNS
$111B
$22K 0.01%
400
– –
2015 Q1
17 quarters
EXP icon
99
Eagle Materials
EXP
$5.22B
$21K 0.01%
228
– –
2013 Q2
24 quarters
VIVE
100
DELISTED
VIVEVE MED INC
VIVE
$17K 0.01%
44
– –
2017 Q2
8 quarters

Similar funds

David M. Knott's Q2 2019 Portfolio in Review

As of Q2 2019, David M. Knott held 121 positions worth $237M, down 5.5% from $251M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

David M. Knott's Q2 2019 filing shows 11 new, 20 increased, 8 reduced and 10 closed positions. Its largest new stake was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K. The largest sale was Capitol Federal Financial, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.

  • David M. Knott's largest Q2 2019 buy was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K.
  • David M. Knott added most to Brightstar Lottery PLC in Q2 2019, an estimated $6.7M increase.
  • David M. Knott's biggest Q2 2019 reduction was Capitol Federal Financial, cutting an estimated $8.97M.
  • David M. Knott fully exited Oracle in Q2 2019, selling an estimated $8.06M.
  • David M. Knott's ten largest holdings make up 59% of its $237M portfolio in Q2 2019.
  • David M. Knott opened 11 new positions and closed 10 in Q2 2019.
  • David M. Knott's portfolio value fell 5.5% quarter-over-quarter to $237M.

Based on David M. Knott's 13F filing for Q2 2019, filed 12 Aug 2019.